Several of the anti-apoptotic proteins, such as Bcl-2 itself, Bcl-XL or Mcl-1, have consistently been found to be overexpressed in hematologic malignancies, such as CLL [4]. This evidence concerns the gene BCL2L1 and B-cell chronic lymphocytic leukemia.